Published in:
01-10-2008 | Symposium Paper
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
Authors:
Karl-Johan Malmberg, Yenan T. Bryceson, Mattias Carlsten, Sandra Andersson, Andreas Björklund, Niklas K. Björkström, Bettina C. Baumann, Cyril Fauriat, Evren Alici, M. Sirac Dilber, Hans-Gustaf Ljunggren
Published in:
Cancer Immunology, Immunotherapy
|
Issue 10/2008
Login to get access
Abstract
Insights into the molecular basis for natural killer (NK) cell recognition of human cancer have been obtained in recent years. Here, we review current knowledge on the molecular specificity and function of human NK cells. Evidence for NK cell targeting of human tumors is provided and new strategies for NK cell-based immunotherapy against human cancer are discussed. Based on current knowledge, we foresee a development where more cancers may be subject to treatment with drugs or other immunomodulatory agents affecting NK cells, either directly or indirectly. We also envisage a possibility that certain forms of cancers may be subject to treatment with adoptively transferred NK cells, either alone or in combination with other therapeutic interventions.